|
US7816492B2
(en)
*
|
1998-11-20 |
2010-10-19 |
Arena Pharmaceuticals, Inc. |
Human G protein-coupled receptors
|
|
USRE42190E1
(en)
|
1998-11-20 |
2011-03-01 |
Arena Pharmaceuticals, Inc. |
Method of identifying a compound for inhibiting or stimulating human G protein-coupled receptors
|
|
US20030017528A1
(en)
*
|
1998-11-20 |
2003-01-23 |
Ruoping Chen |
Human orphan G protein-coupled receptors
|
|
DK1584683T3
(da)
*
|
1998-11-20 |
2007-10-29 |
Arena Pharm Inc |
Human G-protein-koblet orphan receptor RUP3
|
|
US6221660B1
(en)
|
1999-02-22 |
2001-04-24 |
Synaptic Pharmaceutical Corporation |
DNA encoding SNORF25 receptor
|
|
US20030125539A1
(en)
*
|
1999-02-22 |
2003-07-03 |
Synaptic Pharmaceutical Corporation |
DNA encoding SNORF25 receptor
|
|
AU5168700A
(en)
|
1999-05-28 |
2000-12-18 |
Synaptic Pharmaceutical Corporation |
Dna encoding snorf33 receptor
|
|
GB9923177D0
(en)
*
|
1999-09-30 |
1999-12-01 |
Pfizer Ltd |
Novel polypeptide
|
|
EP1226250A2
(en)
*
|
1999-11-03 |
2002-07-31 |
MERCK PATENT GmbH |
Gpcr-kd5 polypeptides and dna sequences thereof
|
|
WO2001036473A2
(en)
*
|
1999-11-16 |
2001-05-25 |
Pharmacia & Upjohn Company |
Human g protein-coupled receptors
|
|
EP1287133B1
(en)
*
|
2000-05-18 |
2006-12-13 |
Bayer HealthCare AG |
Regulation of human dopamine-like g protein-coupled receptor
|
|
EP1338651B9
(en)
*
|
2000-12-01 |
2007-05-09 |
Astellas Pharma Inc. |
Method of screening remedy for diabetes
|
|
US20030064381A1
(en)
*
|
2001-03-07 |
2003-04-03 |
Feder John N. |
Polynucleotide encoding a novel human G-protein coupled receptor, HGPRBMY26, expressed highly in testis and gastrointestinal tissues
|
|
US20030045685A1
(en)
*
|
2001-03-09 |
2003-03-06 |
Tularik Inc. |
Novel receptors
|
|
US7053121B2
(en)
*
|
2001-03-19 |
2006-05-30 |
Trustees Of The University Of Pennsylvania |
Compositions and methods for regulating circadian rhythms
|
|
AU2002318168B2
(en)
|
2002-02-25 |
2007-12-13 |
Vaxiion Therapeutics, Llc |
Minicell compositions and methods
|
|
EP1538217A4
(en)
*
|
2002-09-11 |
2006-09-27 |
Astellas Pharma Inc |
SCREENING METHOD FOR INSULATION STOP ENHANCER
|
|
US20030143590A1
(en)
*
|
2002-11-18 |
2003-07-31 |
Shyam Ramakrishnan |
Regulation of human dopamine-like g protein- coupled receptor
|
|
US20080009551A1
(en)
*
|
2003-04-30 |
2008-01-10 |
Arena Pharmaceuticals, Inc. |
Methods and Compositions for Identifying Modulators of G Protein-Coupled Receptors
|
|
US7083933B1
(en)
*
|
2003-05-09 |
2006-08-01 |
Prosidion Limited |
Methods for identification of modulators of OSGPR116 activity
|
|
ATE500270T1
(de)
*
|
2003-05-20 |
2011-03-15 |
Univ Glasgow |
Materialien und methoden die sich auf g-protein gekoppelte rezeptor oligomere beziehen
|
|
US7309589B2
(en)
*
|
2004-08-20 |
2007-12-18 |
Vironix Llc |
Sensitive detection of bacteria by improved nested polymerase chain reaction targeting the 16S ribosomal RNA gene and identification of bacterial species by amplicon sequencing
|
|
NZ556017A
(en)
*
|
2004-12-24 |
2009-10-30 |
Prosidion Ltd |
G-protein coupled receptor (gpr116) agonists and use thereof for treating obesity and diabetes
|
|
DOP2006000008A
(es)
*
|
2005-01-10 |
2006-08-31 |
Arena Pharm Inc |
Terapia combinada para el tratamiento de la diabetes y afecciones relacionadas y para el tratamiento de afecciones que mejoran mediante un incremento de la concentración sanguínea de glp-1
|
|
US7306203B2
(en)
*
|
2005-01-28 |
2007-12-11 |
Platt Robert E |
Post assembly and spacer for use therewith
|
|
WO2006113236A2
(en)
*
|
2005-04-14 |
2006-10-26 |
Cornell Research Foundation, Inc. |
Novel chemical inhibitors of neutrophil activation through the sac-dependent pathway
|
|
US20090325924A1
(en)
*
|
2005-06-30 |
2009-12-31 |
Stuart Edward |
GPCR Agonists
|
|
MX2007016508A
(es)
|
2005-06-30 |
2008-03-04 |
Prosidion Ltd |
Agonistas del receptor acoplado a la proteina g.
|
|
US7833730B2
(en)
*
|
2006-04-11 |
2010-11-16 |
Arena Pharmaceuticals, Inc. |
Methods of using GPR119 to identify compounds useful for increasing bone mass in an individual
|
|
PE20071221A1
(es)
|
2006-04-11 |
2007-12-14 |
Arena Pharm Inc |
Agonistas del receptor gpr119 en metodos para aumentar la masa osea y para tratar la osteoporosis y otras afecciones caracterizadas por masa osea baja, y la terapia combinada relacionada a estos agonistas
|
|
US7638541B2
(en)
*
|
2006-12-28 |
2009-12-29 |
Metabolex Inc. |
5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
|
|
PE20081849A1
(es)
*
|
2007-01-04 |
2009-01-26 |
Prosidion Ltd |
Derivados de piperidin-4-il-propoxi-benzamida como agonistas de gpcr
|
|
GB0700122D0
(en)
|
2007-01-04 |
2007-02-14 |
Prosidion Ltd |
GPCR agonists
|
|
US20100048625A1
(en)
*
|
2007-01-04 |
2010-02-25 |
Matthew Colin Thor Fyfe |
Piperidine gpcr agonists
|
|
US20100048632A1
(en)
|
2007-01-04 |
2010-02-25 |
Matthew Colin Thor Fyfe |
Piperidine GPCR Agonists
|
|
PE20081659A1
(es)
*
|
2007-01-04 |
2008-10-24 |
Prosidion Ltd |
Agonistas de gpcr
|
|
AU2008279447A1
(en)
*
|
2007-07-19 |
2009-01-29 |
Metabolex, Inc. |
N-azacyclic substituted pyrrole, pyrazole, imidazole, triazole and tetrazole derivatives as agonists of the RUP3 or GPR119 receptor for the treatment of diabetes and metabolic disorders
|
|
WO2009034388A1
(en)
|
2007-09-10 |
2009-03-19 |
Prosidion Limited |
Compounds for the treatment of metabolic disorders
|
|
BRPI0817211A2
(pt)
*
|
2007-09-20 |
2017-05-16 |
Irm Llc |
composto composições como moduladores da atividade de gpr119
|
|
GB0720390D0
(en)
|
2007-10-18 |
2007-11-28 |
Prosidion Ltd |
G-Protein coupled receptor agonists
|
|
GB0720389D0
(en)
|
2007-10-18 |
2008-11-12 |
Prosidion Ltd |
G-Protein Coupled Receptor Agonists
|
|
AU2009231906A1
(en)
*
|
2008-03-31 |
2009-10-08 |
Metabolex, Inc. |
Oxymethylene aryl compounds and uses thereof
|
|
EP2108960A1
(en)
|
2008-04-07 |
2009-10-14 |
Arena Pharmaceuticals, Inc. |
Methods of using A G protein-coupled receptor to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditons modulated by PYY
|
|
US20110230507A1
(en)
*
|
2008-07-10 |
2011-09-22 |
Prosidion Limited |
Piperidine GPCR Agonists
|
|
GB0812642D0
(en)
*
|
2008-07-10 |
2008-08-20 |
Prosidion Ltd |
Compounds
|
|
GB0812649D0
(en)
*
|
2008-07-10 |
2008-08-20 |
Prosidion Ltd |
Compounds
|
|
GB0812648D0
(en)
*
|
2008-07-10 |
2008-08-20 |
Prosidion Ltd |
Compounds
|
|
US20110160222A1
(en)
*
|
2008-11-26 |
2011-06-30 |
Metabolex, Inc. |
Modulators of glucose homeostasis for the treatment of diabetes and metabolic disorders
|
|
EP2379542B1
(en)
|
2008-12-24 |
2013-02-13 |
Cadila Healthcare Limited |
Novel oxime derivatives
|
|
GB0904287D0
(en)
|
2009-03-12 |
2009-04-22 |
Prosidion Ltd |
Compounds for the treatment of metabolic disorders
|
|
GB0904284D0
(en)
|
2009-03-12 |
2009-04-22 |
Prosidion Ltd |
Compounds for the treatment of metabolic disorders
|
|
GB0904285D0
(en)
|
2009-03-12 |
2009-04-22 |
Prosidion Ltd |
Compounds for the treatment of metabolic disorders
|
|
WO2010118404A2
(en)
*
|
2009-04-09 |
2010-10-14 |
California Institute Of Technology |
Methods for creating or identifying compounds that bind tumor necrosis factor alpha
|
|
WO2010146605A1
(en)
|
2009-06-18 |
2010-12-23 |
Cadila Healthcare Limited |
Novel gpr 119 agonists
|
|
AR077214A1
(es)
*
|
2009-06-24 |
2011-08-10 |
Neurocrine Biosciences Inc |
Heterociclos nitrogenados y composiciones farmaceuticas que los contienen
|
|
AU2010264720A1
(en)
*
|
2009-06-24 |
2011-12-08 |
Boehringer Ingelheim International Gmbh |
New compounds, pharmaceutical composition and methods relating thereto
|
|
JP2012228180A
(ja)
*
|
2009-09-02 |
2012-11-22 |
Panasonic Corp |
脂質二重膜の産生方法、化学物質を検知可能とする方法、細胞、カリウムイオンを輸送する方法、および化学物質を検知または定量する方法
|
|
JP2012228181A
(ja)
*
|
2009-09-02 |
2012-11-22 |
Panasonic Corp |
脂質二重膜の産生方法、化学物質を検知可能とする方法、細胞、カリウムイオンを輸送する方法、および化学物質を検知または定量する方法
|
|
JP5909185B2
(ja)
|
2009-10-01 |
2016-04-26 |
シマベイ セラピューティクス， インコーポレーテッド |
置換テトラゾール−１−イルフェノキシメチルチアゾール−２−イルピペリジニルピリミジン塩
|
|
GB201006166D0
(en)
|
2010-04-14 |
2010-05-26 |
Prosidion Ltd |
Compounds for the treatment of metabolic disorders
|
|
GB201006167D0
(en)
|
2010-04-14 |
2010-05-26 |
Prosidion Ltd |
Compounds for the treatment of metabolic disorders
|
|
TW201209054A
(en)
|
2010-05-28 |
2012-03-01 |
Prosidion Ltd |
Novel compounds
|
|
JP5847813B2
(ja)
|
2010-06-23 |
2016-01-27 |
シマベイ セラピューティクス， インコーポレーテッド |
５−エチル−２−｛４−［４−（４−テトラゾル−１−イル−フェノキシメチル）−チアゾール−２−イル］−ピペリジン−１−イル｝−ピリミジンの組成物
|
|
EP2625177B1
(en)
|
2010-10-08 |
2015-07-29 |
Cadila Healthcare Limited |
Novel gpr 119 agonists
|
|
WO2012066077A1
(en)
|
2010-11-18 |
2012-05-24 |
Prosidion Limited |
1,4 di substituted pyrrolidine - 3 - yl -amine derivatives and their use for the treatment of metabolic disorders
|
|
GB201114389D0
(en)
|
2011-08-22 |
2011-10-05 |
Prosidion Ltd |
Novel compounds
|
|
CA2836487A1
(en)
|
2011-06-09 |
2012-12-13 |
Rhizen Pharmaceuticals Sa |
Novel compounds as modulators of gpr-119
|
|
AU2017305392A1
(en)
|
2016-08-03 |
2019-02-21 |
Cymabay Therapeutics, Inc. |
Oxymethylene aryl compounds for treating inflammatory gastrointestinal diseases or gastrointestinal conditions
|